Studies have shown that ARMCX5 can be activated by binding to the oncogene ZnF217 [35] and ARMCX6 upexpressed at least 2-fold in peripheral blood monocytes of rheumatoid arthritis patients compared to those identified using oligonucleotide array [36]. This evidence concerns the gene ZNF217 and rheumatoid arthritis.